Recital 11, Decision_act (EU) 2026/393

In forcesince 17 Feb 2026

Given the updated protection and surveillance zones, including those that have expired and been lifted in the western part of the departments of Hautes-Pyrénées, Gers and Pyrénées-Atlantiques, in France, it is necessary to adjust the vaccination zones I and II for infection with lumpy skin disease virus currently, in that Member State, set out in Annex II to Implementing Decision (EU) 2025/1708.